Institutional investors control 12.72% of the outstanding shares in GSK. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended June 2019, these large investors purchased a net $356.8 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DODGE & COX Bought 14.1 Million shares of GlaxoSmithKline PLC
ARROWSTREET CAPITAL LP Bought 3.3 Million shares of GlaxoSmithKline PLC
CAMBER CAPITAL MANAGEMENT LP Bought 3.1 Million shares of GlaxoSmithKline PLC